| 1 |
34158343 | The Radiosensitizing Effect of AZD0530 in Glioblastoma and Glioblastoma Stem-Like Cells. | 2021 Sep |
1 |
| 2 |
31805962 | Simultaneously inactivating Src and AKT by saracatinib/capivasertib co-delivery nanoparticles to improve the efficacy of anti-Src therapy in head and neck squamous cell carcinoma. | 2019 Dec 5 |
2 |
| 3 |
29550144 | miR-19b-3p inhibits breast cancer cell proliferation and reverses saracatinib-resistance by regulating PI3K/Akt pathway. | 2018 May 1 |
1 |
| 4 |
24200972 | Src and CXCR4 are involved in the invasiveness of breast cancer cells with acquired resistance to lapatinib. | 2014 |
1 |
| 5 |
24492292 | The ErbB2-targeting antibody trastuzumab and the small-molecule SRC inhibitor saracatinib synergistically inhibit ErbB2-overexpressing gastric cancer. | 2014 Mar-Apr |
1 |
| 6 |
22450814 | Distinct effects of saracatinib on memory CD8+ T cell differentiation. | 2012 May 1 |
1 |
| 7 |
19240653 | The Src inhibitor AZD0530 blocks invasion and may act as a radiosensitizer in lung cancer cells. | 2009 Apr |
1 |
| 8 |
19451593 | Combined Src and aromatase inhibition impairs human breast cancer growth in vivo and bypass pathways are activated in AZD0530-resistant tumors. | 2009 May 15 |
1 |